Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis
View abstract on PubMed
Summary
This summary is machine-generated.Molecular imaging offers a noninvasive method for early liver fibrosis detection. This approach aids in diagnosis, staging, and treatment monitoring of liver fibrosis, outperforming conventional methods.
Area Of Science
- Biomedical imaging
- Molecular biology
- Hepatology
Background
- Liver fibrosis is a pathological response to chronic liver injury, potentially leading to cirrhosis and cancer.
- Early-stage liver fibrosis is reversible but challenging to diagnose using conventional imaging techniques.
- Probe-assisted molecular imaging presents a noninvasive strategy for visualizing early fibrosis in vivo.
Purpose Of The Study
- To review recent advancements in molecular imaging technologies for liver fibrosis.
- To summarize biological targets and imaging modalities for liver fibrosis diagnosis.
- To discuss challenges and opportunities for clinical translation of these technologies.
Main Methods
- Review of current literature on molecular imaging for liver fibrosis.
- Illustration of liver fibrosis pathogenesis, including cellular and molecular processes.
- Summary of biological targets (receptors on hepatic stellate cells, macrophages, collagen) and imaging modalities.
Main Results
- Molecular imaging enables visualization of early fibrosis, aiding diagnosis and staging.
- Advances in imaging modalities and contrast agents are crucial for liver fibrosis detection.
- Identification of specific biological targets enhances imaging specificity.
Conclusions
- Molecular imaging is a promising tool for early, noninvasive diagnosis and management of liver fibrosis.
- Further research and clinical translation are needed to optimize molecular imaging techniques and contrast agents.
- This review serves as a guide for researchers and clinicians in liver fibrosis imaging and treatment.

